adds “Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” new report to its research database. The report spread across in a 122 pages with table and figures in it.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

 Request a sample copy @:

Scope of the Report: This report focuses on the Platinum based Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.

The worldwide market for Platinum based Cancer Drug is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 1580 million US$ in 2023, from 1290 million US$ in 2017,

Market Segment by Manufacturers, this report covers

  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy’s Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Market Segment by Regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse full table of contents and data tables @:

Market Segment by Type, covers

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Other

Market Segment by Applications, can be divided into

  • Colorectal Cancer
  • OvarianCancer
  • Lung Cancer
  • Other

There are 15 Chapters to deeply display the global Platinum based Cancer Drug market.

  • Chapter 1, to describe Platinum based Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
  • Chapter 2, to analyze the top manufacturers of Platinum based Cancer Drug, with sales, revenue, and price of Platinum based Cancer Drug, in 2016 and 2017;
  • Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
  • Chapter 4, to show the global market by regions, with sales, revenue and market share of Platinum based Cancer Drug, for each region, from 2013 to 2018;
  • Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
  • Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
  • Chapter 12, Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
  • Chapter 13, 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Order a purchase Report Copy @:

About Us: is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the Globe’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Contact Us:-

Mr. Jeet Jain

Sales Manager



Connect with us:  Google+ | LinkedIn | Twitter | Facebook